It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Stromal interaction molecule−1 and −2 (STIM1/2) are endoplasmic reticulum (ER) membrane-inserted calcium (Ca2+) sensing proteins that, together with Orai1-composed Ca2+ channels on the plasma membrane (PM), regulate intracellular Ca2+ levels. Recent evidence suggests that S-nitrosylation of the luminal STIM1 Cys residues inhibits store operated Ca2+ entry (SOCE). However, the effects of thiol modifications on STIM2 during nitrosative stress and their role in regulating basal Ca2+ levels remain unknown. Here, we demonstrate that the nitric oxide (NO) donor nitrosoglutathione (GSNO) thermodynamically stabilizes the STIM2 Ca2+ sensing region in a Cys-specific manner. We uncovered a remarkable synergism in this stabilization involving the three luminal Cys of STIM2, which is unique to this paralog. S-Nitrosylation causes structural perturbations that converge on the face of the EF-hand and sterile α motif (EF-SAM) domain, implicated in unfolding-coupled activation. In HEK293T cells, enhanced free basal cytosolic Ca2+ and SOCE mediated by STIM2 overexpression could be attenuated by GSNO or mutation of the modifiable Cys located in the luminal domain. Collectively, we identify the Cys residues within the N-terminal region of STIM2 as modifiable targets during nitrosative stress that can profoundly and cooperatively affect basal Ca2+ and SOCE regulation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Schulich School of Medicine and Dentistry, the University of Western Ontario, London, Department of Physiology and Pharmacology, Ontario, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884)
2 Schulich School of Medicine and Dentistry, the University of Western Ontario, London, Department of Physiology and Pharmacology, Ontario, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Dentistry, Schulich School of Medicine and Dentistry, the University of Western Ontario, London, Ontario, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884)
3 Schulich School of Medicine and Dentistry, the University of Western Ontario, London, Department of Physiology and Pharmacology, Ontario, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255)